We regret to report that long term Biogen Inc. (NASDAQ:BIIB) shareholders have had that experience, with the share price dropping 20% in three years, versus a market return of about 89%.

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

At $310.58, the average BIIB stock price target of $310.58 suggests a modest upside potential of 1.8% from current levels. Biogen stock has rallied over 27% so far this year. IQVIA Holdings (IQV ...

Biogen (NASDAQ:BIIB) has had a great run on the share market with its stock up by a significant 30% over the last three months. Given the company's impressive performance, we decided to study its ...

Biogen Inc. (BIIB) closed the most recent trading day at $285.37, moving -1.29% from the previous trading session. This move lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow lost 0.9% ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the May 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Another notable valuation metric for BIIB is its P/B ratio of 3.26. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities.

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the September 2025 expiration. One of the key data points that goes into the price an option buyer is willing to ...

Our analysis of options history for Biogen (NASDAQ: BIIB) revealed 12 unusual trades. Delving into the details, we found 25% of traders were bullish, while 66% showed bearish tendencies.

Another notable valuation metric for BIIB is its P/B ratio of 2.52. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities.

And the worst performing Nasdaq 100 component thus far on the day is Biogen (BIIB), trading down 5.0%. Biogen is lower by about 10.1% looking at the year to date performance.

VIDEO: Nasdaq 100 Movers: BIIB, GILD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.